SEMAGLUTIDE 10mg/ recalled over sterility concerns
- Recall date
- August 22, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- ProRx LLC recalls SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 8…
- Recall number
- D-0653-2024
- FDA classification
- Class II
- Brand / firm
- ProRx LLC
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
SEMAGLUTIDE 10mg/4mL (2.5mg/mL), 4 mL Multiple Dose Vial, Rx Only, Compounded Drug, Mfd by: ProRX Exton, PA19341, NDC 84139-225-04
Get recall alerts
Free email alert whenever ProRx LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: ProRx LLC